L. Barkal

Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy

I. Weissman, A. Barkal, B. George, 2017, Nature Immunology.

Microbial metabolomics in open microscale platforms

David J. Beebe, Kenneth A. Brakke, Erwin Berthier, 2016, Nature Communications.